Bio-Path Holdings Reports Third Quarter 2013 Operational and Financial Results

18-11-2013 Business Wire HealthComments (0)

Biotechnology

Bio-Path Holdings, Inc., (OTCQX: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced operational and financial results for the third quarter ended September 30, 2013. THIRD QUARTER 2013 OPERATIONAL AND FINANCIAL HIGHLIGHTS Recent Operational Highlights During the quarter, two patients completed treatment in the sixth dosage cohort of Bio-Path’s Phase I clinical trial evaluating its lead p

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top